Granulocyte-colony Stimulating Factors or Antibiotics for Primary Prophylaxis for Febrile Neutropenia

NCT02816112 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

458

Enrollment

OTHER

Sponsor class

Conditions

Early Stage Breast Cancer

Interventions

DRUG: Ciprofloxacin
DRUG: Neupogen

Sponsor

Ottawa Hospital Research Institute